|
- Bausch + Lomb Announces Launch of Senior Secured Notes Offering and . . .
Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement Jun 10 2025 VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+Lomb Netherlands B V
- Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife . . .
Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens May 07 2025 VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced CE Mark approval for the LuxLife full range of vision intraocular lens (IOL)
- Bausch + Lomb Official Home Page
Bausch + Lomb is one of the world's largest suppliers of contact lenses, lens care products, prescription pharmaceuticals, intraocular lenses and other eye surgery products
- Bausch + Lomb Launches Arise™ Orthokeratology Lens System in the United . . .
Bausch + Lomb Launches Arise™ Orthokeratology Lens System in the United States Mar 17 2025 VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U S launch of Arise, a lens fitting system that uses intelligent, cloud-based technology to streamline the
- SEC Filings | Bausch + Lomb Corporation
©2025 Bausch + Lomb MTB 0115 USA 21 All Information and m aterials on this site pertain to the U S only, unless otherwise indicated
- Bausch + Lomb Products for Eye Care and Contact Lenses
©2025 Bausch + Lomb MTB 0115 USA 21 All Information and m aterials on this site pertain to the U S only, unless otherwise indicated
- Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and . . .
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance Feb 21 2024 Fourth-Quarter 2023 Financial Results Revenue of $1 173 Billion; GAAP Net Loss Attributable to Bausch + Lomb Corporation of $54 Million; Adjusted EBITDA (non-GAAP) 1 of $231 Million Revenue Grew 18% as Reported and 19% on a Constant Currency 1 Basis Compared to the Fourth Quarter of 2022
- Investor Relations | Bausch + Lomb Corporation
Bausch + Lomb Corporation (NYSE TSX: BLCO) is a leading global eye health company that is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life
|
|
|